Among the secondary outcomes , the intention-to-treat analyses also demonstrated that patients in the MCT group had significantly greater reductions in the PANSS positive syndrome score ( 2partial = .055 ; P = .02 ) and the Psychotic Symptom Rating Scales delusion score ( 2partial = .109 ; P = .001 ) .